Buy Aurobindo Pharma, Radico Khaitan, KPIT Tech: D Cunha

In CNBC-TV18's popular show Bull's Eye, Lancelot D Cunha of ITI Wealth shares his trading strategies for the day.

One may buy Aurobindo Pharma. It has been moving up in the past few trading sessions on good volumes in anticipation of good results post the approval received from the USFDA on its plants and we also expect that we could see some amount of FII buying in the stock as most of the FIIs have been major holders in the stock. Given that background, expect the buying to continue and we could see the stock move to its target price of Rs 228. One may buy SKS Microfinance. The stock has been showing good improvement in its performance. The company has successfully been able to transfer its debt to securitization and that has helped the cash flows over the company, it has also improved its credit ratings and is expected to perform with better results which are seen. There is some informed buying that is taking place in counter and expect buying to continue and the stock could move up further. One may buy Radico Khaitan with a target price of Rs 159. The stock has been moving up over the past few trading sessions on good volumes. I expect the buying to continue, the company is expected to report good results and has also been looking at restructuring its businesses. This could be positive for the company on a valuation basis. I expect this to move up during the day and it would hit its target price of Rs 159. One may buy KPIT Technologies with a target of around Rs 148.40 with a stoploss Rs 142.50.